A malignant (cancerous) growth in the parathyroid gland is referred to as parathyroid cancer. It is a rare cancer that can develop in any of the four parathyroid glands, which are a part of the endocrine system.
Depending on the type of cancer, there are different parathyroid cancer stages that can typically be classified as localized, metastatic, or recurrent.
There are three types of parathyroid cancer which are as follows :
The term localized parathyroid cancer refers to a cancer that has spread to surrounding tissues after initially developing in the parathyroid gland.
Metastasis is the medical term for cancer that has spread to another area of the body. Cancerous cells separate from the original tumor, where they first appeared, and move through the lymphatic or circulatory systems. Metastatic parathyroid cancer spreads to lymph nodes, liver, lungs, bones, and pancreas.
After initial treatment, which is often surgical removal of the malignant gland, parathyroid cancer is said to be recurrent if it returns. Cancer typically returns two to five years after the initial operation, although it may take up to twenty years.
Parathyroid cancer signs include:
Surgery is the primary treatment for parathyroid tumors, whether they are malignant or benign. During surgery, patients have their tumor removed along with some healthy tissue surrounding it.
High-energy x-rays or other particles are used in radiation treatment to fight cancer. Radiation therapy often includes a specified number of sessions spread over a fixed timeframe.
Chemotherapy is the use of medications to kill cancer cells, typically by preventing the growth, division, and production of new cancer cells.
The following tests and treatments might be done before the operation to remove hyperactive parathyroid gland:
Our patients have access to a multispecialty team of professionals at ACTC, who work together in a highly collaborative and coordinated manner to provide all aspects of cancer care in one convenient location in Brooksville, Florida. Our doctors are supported by a clinical team with over two decades of experience and a reputation for providing tailored and supportive cancer care.
The following are our providers who you can consult at ACTC:
Once diagnosed with cancer, you face a series of hard choices. Our experts at ACTC will guide you and your family through every step of cancer treatment. With state-of-the-art technology and experienced cancer specialists, ACTC promises its patients world-class healthcare.
Your form has been sent successfully.
Parathyroid carcinoma is an extremely rare endocrine cancer that was first identified in 1933. This accounts for 0.5 to 5% of all primary hyperparathyroidism cases.
It takes time for parathyroid cancer to spread. It is also quite challenging to diagnose.
Cancer of the parathyroid has no recognized cause. This disease is more common in people who have the hereditary disorders multiple endocrine neoplasia type I and hyperparathyroidism-jaw tumor syndrome. Additionally, individuals who have undergone head or neck radiation may be at higher risk.